Early CMR established a diagnosis in 86% of patients with troponin-positive chest pain and non-obstructed arteries, with CMR diagnosis strongly predicting 4-year all-cause mortality (P<0.0001).
Cohort (n=255)
Does early cardiac magnetic resonance imaging provide diagnostic and prognostic value in patients with troponin-positive acute chest pain and non-obstructed coronary arteries?
Early CMR successfully identifies the underlying etiology in 86% of patients with troponin-positive chest pain and non-obstructed coronary arteries, and strongly stratifies long-term mortality risk.
p-value: p=<0.0001
OBJECTIVE: We assessed the diagnostic and prognostic implications of early cardiac magnetic resonance (CMR), CMR-based deformation imaging and conventional risk factors in patients with troponin-positive acute chest pain and non-obstructed coronary arteries. METHODS: In total, 255 patients presenting between 2009 and 2019 with troponin-positive acute chest pain and non-obstructed coronary arteries who underwent CMR in ≤7 days were followed for a clinical endpoint of all-cause mortality. Cine movies, T2-weighted and late gadolinium-enhanced images were evaluated to establish a diagnosis of the underlying heart disease. Further CMR analysis, including left ventricular strain, was carried out. RESULTS: CMR (performed at a mean of 2.7 days) provided the diagnosis in 86% of patients (54% myocarditis, 22% myocardial infarction (MI) and 10% Takotsubo syndrome and myocardial contusion (n=1)). The 4-year mortality for a diagnosis of MI, myocarditis, Takotsubo and normal CMR patients was 10.2%, 1.6%, 27.3% and 0%, respectively. We found a strong association between CMR diagnosis and mortality (log-rank: 24, p<0.0001). Takotsubo and MI as the diagnosis, age, hypertension, diabetes, female sex, ejection fraction, stroke volume index and most of the investigated strain parameters were univariate predictors of mortality; however, in the multivariate analysis, only hypertension and circumferential mechanical dispersion measured by strain analysis were independent predictors of mortality. CONCLUSIONS: CMR performed in the early phase establishes the proper diagnosis in patients with troponin-positive acute chest pain and non-obstructed coronary arteries and provides additional prognostic factors. This may indicate that CMR could play an additional role in risk stratification in this patient population.
Vágó et al. (2020) conducted a cohort in Troponin-positive acute chest pain and non-obstructed coronary arteries (n=255). Early cardiac magnetic resonance (CMR) was evaluated on All-cause mortality (p=<0.0001). Early CMR established a diagnosis in 86% of patients with troponin-positive chest pain and non-obstructed arteries, with CMR diagnosis strongly predicting 4-year all-cause mortality (P<0.0001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: